Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1O-15 water----1件: 6 💬
2O2, GAS FOR medical purposes----1件: 211 💬
3OAT1件: Oat---1件: 46 💬
4OATD-01----1件: 84 💬
5OAV101----1件: 3 💬
6Obatoclax1件: Obatoclax1件: Obatoclax mesylate 💬 1件: BCL2 💬 40件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 60 💬
7OBE-CEL1件: Obecabtagene autoleucel1件: Obecabtagene autoleucel 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 49 💬
8Obecabtagene autoleucel1件: Obecabtagene autoleucel1件: Obecabtagene autoleucel 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 49 💬
9Obefazimod----2件: 96, 97 💬
10Obese----1件: 75 💬
11Obeticholic acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬3件: 93, 265, 296 💬
12Obeticholic acid 10 MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
13Obeticholic acid 5 MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
14Obeticholic acid tablets1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
15Obexelimab1件: Obexelimab1件: Obexelimab 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬4件: 13, 49, 61, 300 💬
16OBI-1----1件: 288 💬
17Obinutuzumab1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬5件: 43, 44, 49, 63, 222 💬
18Obinutuzumab administration1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 49 💬
19Obinutuzumab injection1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
20Obinutuzumab/ GA1011件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
21Obitunuzumab----1件: 222 💬
22Obizur----1件: 288 💬
23Observation----1件: 265 💬
24Observation OF ocrelizumab AS treatment IN rrms patients----1件: 13 💬
25Observation only----1件: 331 💬
26Observational----1件: 90 💬
27Observational cohort----1件: 6 💬
28Observational control----1件: 13 💬
29Observational study----2件: 46, 271 💬
30Observational study TO examine safety, tolerability, and effectiveness OF spinraza® prescribed AS part OF standard OF care----1件: 3 💬
31Observational study with patients treated with tracleer, ventavis, veletri, opsumit and/or uptravi----1件: 86 💬
32Obyoctocog alfa----1件: 288 💬
33OC oral solution treatment A----1件: 6 💬
34OC oral solution treatment B----1件: 6 💬
35OC oral solution treatment C----1件: 6 💬
36OC oral solution treatment D----1件: 6 💬
37OC000459----1件: 98 💬
38OC3----1件: 234 💬
39OC5----1件: 234 💬
40OCA----3件: 93, 94, 296 💬
41OCA 0.1 MG----1件: 296 💬
42OCA 0.1MG----1件: 296 💬
43OCA 1,5 MG----1件: 94 💬
44OCA 1.5MG----1件: 296 💬
45OCA 5 MG----1件: 94 💬
46OCA 5MG----1件: 296 💬
47Ocaliva1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬2件: 93, 296 💬
48Ocaliva 10MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
49Ocaliva 5MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
50Occlusive NON adherent dressing----1件: 36 💬
51OCH-NCNP1----1件: 13 💬
52Oclelizumab----1件: 13 💬
53OCR----1件: 13 💬
54Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬4件: 11, 13, 46, 49 💬
55Ocrelizumab / rhumab 2h71件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
56Ocrelizumab 300 MG1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
57Ocrelizumab 300MG1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
58Ocrelizumab 300MG/10 ML1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
59Ocrelizumab 300MG/10ML1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
60Ocrelizumab 500MG1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
61Ocrelizumab 600 MG1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
62Ocrelizumab AT home1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
63Ocrelizumab dose 11件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
64Ocrelizumab dose 2 and dose 31件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
65Ocrelizumab IV1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
66Ocrelizumab SC1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
67Ocrelizumabu 200MG----1件: 46 💬
68Ocrelizumabu 50MG----1件: 46 💬
69Ocrevus1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
70Ocrevus 300 MG, solution à diluer pour perfusion1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
71Ocrevus-EU----1件: 13 💬
72Ocrevus-US----1件: 13 💬
73Ocrh----2件: 75, 232 💬
74Ocrrelizumab 300 MG----1件: 13 💬
75OCTA-C1-INH----1件: 65 💬
76Octaalpha1----1件: 231 💬
77Octagam1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 13, 65 💬
78Octagam 50 MG/ML1件: Human immunoglobulin G1件: Globulin, immune 💬 --1件: 13 💬
79Octanate 100 UI/ML, poudre ET solvant pour solution injectable----1件: 288 💬
80Octanate 50 UI/ML, poudre ET solvant pour solution injectable----1件: 288 💬
81Octanorm----2件: 50, 65 💬
82Octaplas----1件: 64 💬
83Octaplas infusion----1件: 64 💬
84Octaplas SD----1件: 64 💬
85Octaplas®LG----1件: 64 💬
86Octeotride----1件: 67 💬
87Octocog alfa1件: Antihemophilic factor, human recombinant1件: Octocog alfa 💬 1件: F8 💬 1件: Complement and coagulation cascades 💬1件: 288 💬
88Octostim----2件: 64, 288 💬
89Octreolin----1件: 77 💬
90Octreotid----1件: 77 💬
91Octreotida1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
92Octreotida acetato1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
93Octreotidacetat----1件: 77 💬
94Octreotide1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬8件: 67, 75, 77, 84, 85, 89, 193, 227 💬
95Octreotide A azione pronta 0,1 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 227 💬
96Octreotide acetate1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 77, 227 💬
97Octreotide acetate 30 MG suspension1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
98Octreotide acetate and cabergoline/octrotide and somavert1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
99Octreotide acetate microspheres FOR injection injection1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
100Octreotide acetate prolonged release, 30 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
101Octreotide acetato1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 77, 227 💬
102Octreotide capsules1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
103Octreotide fluidcrystal® injection depot1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
104Octreotide hydrochloride1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
105Octreotide implant1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
106Octreotide LAR1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 77, 227 💬
107Octreotide LAR 30 MG injection1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
108Octreotide LAR 30MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
109Octreotide-LAR1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 67, 77 💬
110Octreotide-LAR or lanreotide1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
111OCU4001件: OCU400---1件: 90 💬
112OCU400 high dose1件: OCU400---1件: 90 💬
113OCU400 LOW dose1件: OCU400---1件: 90 💬
114OCU400 MED dose1件: OCU400---1件: 90 💬
115OCU410ST1件: OCU410ST---1件: 301 💬
116Ocufolin----1件: 13 💬
117OD-07656----3件: 96, 97, 110 💬
118Odevixibat1件: Odevixibat1件: Odevixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬3件: 296, 297, 338 💬
119Odiparcil1件: Odiparcil---1件: 19 💬
120ODM-101----1件: 6 💬
121ODM-101 105MG carbidopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
122ODM-101 65MG carbidopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
123ODM-104----1件: 6 💬
124ODM-109----1件: 2 💬
125ODM-109 capsule 1 MG----1件: 2 💬
126Odsh AT 0.125 MG/KG/H----1件: 210 💬
127Odsh AT 0.250 MG/KG/H----1件: 210 💬
128Odsh AT 0.375 MG/KG/H----1件: 210 💬
129Oestrogen----1件: 78 💬
130Ofatumumab1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬4件: 11, 13, 35, 46 💬
131Ofatumumab 1001件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
132Ofatumumab 3001件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
133Ofatumumab 30MG1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
134Ofatumumab 3MG1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
135Ofatumumab 60MG1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
136Ofatumumab 7001件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
137Ofatumumab approved dose1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
138Ofatumumab NEW dose1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
139Ofatumumab subcutaneous injection1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 13, 35 💬
140Ofatumumab with AI1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
141Ofatumumab with PRF1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
142Ofatunumab----1件: 13 💬
143Ofev1件: Nintedanib2件: Nintedanib esylate ,
Nintedanib 💬 		8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬 		33件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬5件: 51, 85, 89, 227, 228 💬
144Ofev 100 MG capsule1件: Nintedanib2件: Nintedanib esylate ,
Nintedanib 💬 		8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬 		33件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
145Ofev 150 MG capsule1件: Nintedanib2件: Nintedanib esylate ,
Nintedanib 💬 		8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬 		33件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
146OFF dopaminergic medication----1件: 6 💬
147OFF-label compassionate drug USE----1件: 21 💬
148OGT 918----2件: 19, 299 💬
149OGT918----1件: 19 💬
150OGT923----1件: 19 💬
151Ogtt----2件: 77, 299 💬
152OK432----1件: 278 💬
153Okrido 6MG/ML oral solution----1件: 3 💬
154Oksikodoni----1件: 70 💬
155OL adalimumab 40 MG1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
156OL-108----2件: 49, 51 💬
157Olanzapine1件: Olanzapine2件: Olanzapine ,
Olanzapine pamoate 💬 		11件: ADRA1A,
ADRA1B,
ADRA1D,
DRD2,
DRD3,
DRD4,
HRH1,
HTR2,
HTR2,
HTR2,
HTR6 💬 		18件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 8 💬
158Olaparib1件: Olaparib1件: Olaparib 💬 2件: PARP1,
PARP2 💬 		5件: Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 💬2件: 86, 285 💬
159OLE BSA adalimumab +/- MTX----1件: 107 💬
160OLE FD adalimumab +/- MTX----1件: 107 💬
161Oleic acid supplementation1件: Oleic Acid1件: Oleic acid 💬 --1件: 299 💬
162Olenasufligene relduparvovec1件: Olenasufligene relduparvovec---1件: 19 💬
163Oleogel-S101件: Birch bark extract1件: Birch triterpenes 💬 --1件: 36 💬
164Oleovit D3 14.400 IU/ML oral drops, solution----1件: 13 💬
165Olesoxime1件: Olesoxime1件: Olesoxime 💬 --3件: 2, 3, 13 💬
166Olfactory (smell) function testing----1件: 122 💬
167Oligofructose enriched inulin----1件: 96 💬
168Oligofructose-enriched inulin OI----1件: 97 💬
169Oligog----1件: 299 💬
170Oligog CF-5/20----1件: 299 💬
171Oligog CF-5/20 - 17.5 MG----1件: 299 💬
172Oligog CF-5/20, 17,5 MG, hartkapsel MIT pulver ZUR inhalation----1件: 299 💬
173Oligog CF/20 - 27.5 MG----1件: 299 💬
174Oligog CF/20 - 37.5 MG----1件: 299 💬
175Oligog CF/20, 27,5 MG, hartkapsel MIT pulver ZUR inhalation----1件: 299 💬
176Oligog CF/20, 37,5 MG, hartkapsel MIT pulver ZUR inhalation----1件: 299 💬
177Oligog DPI----1件: 299 💬
178Oligog-CF5/20, alginate oligosaccharide (G-block) fragment----1件: 299 💬
179Oligomer OF sodium alginate----1件: 299 💬
180Oligomero morfolino fosforodiamidato PER skipping dell’esone 45----1件: 113 💬
181Oligomero morfolino fosforodiamidato PER skipping dell’esone 53----1件: 113 💬
182Olikizumab----1件: 46 💬
183Olimel parenteral nutrition----1件: 97 💬
184Olipudase alfa1件: Olipudase alfa1件: Olipudase alfa 💬 1件: SMPD1 💬 4件: Lysosome, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬1件: 19 💬
185Olive OIL2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬 --3件: 34, 49, 53 💬
186Olokizumab1件: Olokizumab1件: Olokizumab 💬 1件: IL6 💬 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬2件: 46, 96 💬
187Olokizumab 120 MG1件: Olokizumab1件: Olokizumab 💬 1件: IL6 💬 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
188Olokizumab 240 MG1件: Olokizumab1件: Olokizumab 💬 1件: IL6 💬 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
189Olokizumab 60 MG1件: Olokizumab1件: Olokizumab 💬 1件: IL6 💬 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
190Olokizumab 64 MG SC Q2W1件: Olokizumab1件: Olokizumab 💬 1件: IL6 💬 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
191Olokizumab 64 MG SC Q4W1件: Olokizumab1件: Olokizumab 💬 1件: IL6 💬 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
192Olokizumab 64MG Q2W1件: Olokizumab1件: Olokizumab 💬 1件: IL6 💬 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
193Olokizumab 64MG Q4W1件: Olokizumab1件: Olokizumab 💬 1件: IL6 💬 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
194Olsalazine1件: Olsalazine2件: Olsalazine sodium ,
Olsalazine 💬 		--1件: 271 💬
195Olumiant1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬9件: 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
196Olumiant - EU/1/16/1170/001-0081件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
197Olumiant - EU/1/16/1170/009-0161件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
198Olumiant 2 MG/4 MG filmtabletten1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
199Olumiant 4 MG1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
200Olumiant 4MG1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 50 💬
201Olumiant® 2 MG compriméS PélliculéS1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 50 💬
202Oluminant----1件: 107 💬
203OM meditation----1件: 6 💬
204Omacor----1件: 49 💬
205Omadacycline1件: Omadacycline2件: Omadacycline ,
Omadacycline tosylate 💬 		--1件: 299 💬
206Omalizumab1件: Omalizumab1件: Omalizumab 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299 💬
207Omaveloxolone1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
208Omaveloxolone capsules, 10 MG1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
209Omaveloxolone capsules, 150 MG1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
210Omaveloxolone capsules, 160 MG1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
211Omaveloxolone capsules, 2.5 MG1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
212Omaveloxolone capsules, 20 MG1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
213Omaveloxolone capsules, 300 MG1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
214Omaveloxolone capsules, 40 MG1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
215Omaveloxolone capsules, 5 MG1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
216Omaveloxolone capsules, 80 MG1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
217OMB157----1件: 13 💬
218OMB157G----1件: 13 💬
219Omega 3 fatty acid----1件: 53 💬
220Omega 3 fatty acids1件: Omega-3 fatty acids---1件: 13 💬
221Omega 3 premium----1件: 299 💬
222Omega-31件: Omega-3 fatty acids---3件: 46, 49, 96 💬
223Omega-3 and vitamin E supplementation1件: Omega-3 fatty acids---1件: 46 💬
224Omega-3 fatty acid1件: Omega-3 fatty acids---1件: 46 💬
225Omega-3 fatty acid ethylester901件: Omega-3 fatty acids---1件: 66 💬
226Omega-3 fatty acid fish OIL supplement1件: Omega-3 fatty acids---1件: 66 💬
227Omega-3 fatty acids1件: Omega-3 fatty acids---2件: 13, 79 💬
228Omega-3 supplementation1件: Omega-3 fatty acids---1件: 46 💬
229Omega-3 triglycerides1件: Omega-3 fatty acids---1件: 299 💬
230Omega-3-acid triglycerides1件: Omega-3 fatty acids---1件: 299 💬
231Omegaven1件: Fish oil---1件: 96 💬
232Omegaven (10% FISH-OIL emulsion----1件: 46 💬
233Omeprazol1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 96, 294 💬
234Omeprazole1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬12件: 6, 13, 21, 46, 85, 90, 96, 97, 98, 271, 282, 298 💬
235Omeprazole 20 MG1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 96, 97 💬
236Omeprazole 20 MG oral tablet1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 98 💬
237Omeprazole 20MG1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 51 💬
238Omeprazole 20MG BID1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 98 💬
239Omeprazole 20MG capsule1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 299 💬
240Omeprazole 40 MG1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 96 💬
241Omeprazole enteric capsules1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 46 💬
242Omeprazole magnesium1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 225 💬
243Omeprazole rectally 1MG/KG1件: Omeprazole3件: Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 294 💬
244Omidubicel1件: Omidubicel1件: Omidubicel 💬 1件: CD34 💬 2件: Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 60 💬
245Omigapil1件: Omigapil---1件: 113 💬
246Omnipaque1件: Iohexol1件: Iohexol 💬 --2件: 19, 222 💬
247Omnitrope1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 193 💬
248OMS00620646, OMS620646, MASP-2 antibody----1件: 109 💬
249OMS643762----1件: 8 💬
250OMS721----4件: 64, 66, 109, 222 💬
251OMS721 100 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody----2件: 64, 109 💬
252OMS721 185 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody----2件: 64, 109 💬
253OMS721 drug product 185 MG/ML----1件: 109 💬
254OMS906 study drug1件: OMS906---1件: 62 💬
255OMS906 study drug - 3 MG/KG1件: OMS906---1件: 62 💬
256OMS906 study drug - 5 MG/KG1件: OMS906---1件: 62 💬
257OMT-28----1件: 21 💬
258ON 01910.NA----1件: 36 💬
259ON dopaminergic medication----1件: 6 💬
260ON-demand treatment----1件: 299 💬
261Onabotulinum toxin A----1件: 226 💬
262Onabotulinumtoxin A----2件: 51, 226 💬
263Onabotulinumtoxin A injection----1件: 6 💬
264Onabotulinumtoxina1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬2件: 6, 13 💬
265Onabotulinumtoxina FOR injection1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 149 💬
266Onasemnogene abeparvovec1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬 --1件: 3 💬
267Onasemnogene abeparvovec-xioi1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬 --1件: 3 💬
268Once A DAY trientine----1件: 171 💬
269ONCE-daily insulin detemir----1件: 299 💬
270Oncolytic measles virus encoding thyroidal sodium iodide symporter----1件: 34 💬
271Oncoxin + viusid----1件: 46 💬
272Ondansetron1件: Ondansetron2件: Ondansetron ,
Ondansetron hydrochloride hydrate 💬 		5件: HTR3,
HTR3,
HTR3,
HTR3,
HTR3 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬3件: 98, 107, 231 💬
273Ondansetron 8 MG FILM-coated tablets1件: Ondansetron2件: Ondansetron ,
Ondansetron hydrochloride hydrate 💬 		5件: HTR3,
HTR3,
HTR3,
HTR3,
HTR3 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
274Ondansetron hydrochloride dihydrate1件: Ondansetron2件: Ondansetron ,
Ondansetron hydrochloride hydrate 💬 		5件: HTR3,
HTR3,
HTR3,
HTR3,
HTR3 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬2件: 6, 97 💬
275ONE 20cm2/10cm2 autologous skin sheet graft----1件: 160 💬
276ONE additional blood sample during A planned blood test----1件: 266 💬
277ONE alpha drops----2件: 50, 107 💬
278ONE ML contains horse ANTI-human T lymphocyte immunoglobulin (eatg) 50 MG1件: Antilymphocyte immunoglobulin (horse)1件: Anti-human thymocyte immunoglobulin, equine 💬 --1件: 60 💬
279ONE time survey----1件: 3 💬
280ONE-alpha drops1件: Alfacalcidol1件: Alfacalcidol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 50, 107 💬
281ONE-LEG stance test----1件: 13 💬
282Ongentys1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
283Ongentys 50 MG capsule rigide1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
284Ongentys 50 MG hard capsules1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
285Ongentys 50MG----1件: 6 💬
286Only 1 ARM: treatment with MSC-AFP----1件: 96 💬
287ONO-1110----1件: 226 💬
288ONO-2506----1件: 2 💬
289ONO-2506PO----2件: 2, 6 💬
290ONO-2808----1件: 17 💬
291ONO-4059----1件: 35 💬
292ONO-4641----1件: 13 💬
293ONO-4641/ MSC2430913A----1件: 13 💬
294ONO-4641/MSC2430913A----1件: 13 💬
295ONO-5788----1件: 77 💬
296Onpattro1件: Patisiran2件: Patisiran sodium ,
Patisiran 💬 		1件: TTR 💬 1件: Thyroid hormone synthesis 💬1件: 28 💬
297Ontamalimab1件: Ontamalimab---2件: 96, 97 💬
298Opana----1件: 70 💬
299OPC----1件: 6 💬
300OPC-41061----1件: 67 💬
301OPC-6535----2件: 96, 97 💬
302OPCT-001----3件: 90, 301, 303 💬
303Open label - AL0011件: Latozinemab1件: Latozinemab 💬 1件: SORT1 💬 3件: Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬1件: 127 💬
304Open label clemastine with A blinded randomize withdrawal----1件: 179 💬
305Open label namilumab1件: Namilumab---1件: 84 💬
306OPEN-label----1件: 97 💬
307OPEN-label abatacept----1件: 46 💬
308OPEN-label adalimumab----1件: 46 💬
309OPEN-label cdca 250 MG TID1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 263 💬
310OPEN-labeladalimumabrescue----1件: 46 💬
311Operative cystoscopy----1件: 226 💬
312Ophthalmic emulsion----2件: 51, 53 💬
313Ophthalmologic examinations----1件: 299 💬
314Ophthalmology exam----1件: 19 💬
315Opicapone1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
316Opicapone 50 MG1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
317Opicapone 50 MG hard capsules1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
318Opicinumab1件: Opicinumab1件: Opicinumab 💬 --1件: 13 💬
319OPL-CCL2-LPM----1件: 66 💬
320Oprelvekin, interleukin 11, IL-111件: Oprelvekin1件: Oprelvekin 💬 1件: IL11RA 💬 3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
321OPRX-106----1件: 97 💬
322OPRX-106 (plant cells expressing TNFR-FC) 2MG----1件: 97 💬
323OPRX-106 (plant cells expressing TNFR-FC) 8MG----1件: 97 💬
324OPS-2071----1件: 96 💬
325OPS-2071 150 MG----1件: 96 💬
326OPS-2071 300 MG----1件: 96 💬
327OPS-2071 600 MG----1件: 96 💬
328Opsumit1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
329Opsumit 10 MG tablet----1件: 51 💬
330Opsumit®1件: Macitentan1件: Macitentan 💬 2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
331Optical coherence tomography angiography----1件: 41 💬
332Optimal drug therapy----1件: 6 💬
333Optimized antiparkinsonian treatment----1件: 6 💬
334Optimized medical treatment----1件: 6 💬
335Optimized oral treatment----1件: 6 💬
336Optimized prophylactic IM therapy----1件: 19 💬
337Optimized supportive care----1件: 66 💬
338Optinate 5 MG filmcoated tablets----1件: 274 💬
339Optional blood-oxygen-level dependent functionalmri----1件: 6 💬
340Optional lumbar puncture + blood sample----1件: 138 💬
341Optional muscle biopsy----1件: 86 💬
342Optional pharmacogenetic assessment----1件: 6 💬
343Optional prednisone----1件: 127 💬
344Optional sirolimus----1件: 127 💬
345Optison----1件: 96 💬
346Optivate----1件: 288 💬
347Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO methylprednisolone----1件: 97 💬
348Oral administration OF 100 MG KH176 twice daily----1件: 21 💬
349Oral ANTI-parkinson drugs and injection OF botulinum toxin----1件: 6 💬
350Oral ANTI-parkinson'S drugs----1件: 6 💬
351Oral anticoagulant treatment----1件: 86 💬
352Oral aztreonam----1件: 299 💬
353Oral bovine type I collagen----1件: 51 💬
354Oral bovine type II collagen----1件: 46 💬
355Oral budesonide----2件: 97, 98 💬
356Oral cholera vaccine----1件: 97 💬
357Oral ciprofloxacin----1件: 299 💬
358Oral contrast media application----1件: 96 💬
359Oral corticosteroids----4件: 13, 46, 97, 251 💬
360Oral cromolyn sodium----1件: 98 💬
361Oral cyclosporine----1件: 222 💬
362Oral disulfiram----2件: 90, 301 💬
363Oral drops solution----1件: 28 💬
364Oral ERA----1件: 86 💬
365Oral erythromycin----1件: 36 💬
366Oral escitalopram----1件: 6 💬
367Oral ferrous sulfate----1件: 97 💬
368Oral glucocorticoids----1件: 13 💬
369Oral glucose tolerance test----6件: 6, 13, 77, 160, 195, 299 💬
370Oral glucose tolerance test (ogtt) assessment ARM----1件: 299 💬
371Oral glucose tolerance testing----1件: 77 💬
372Oral glutathione----1件: 299 💬
373Oral ifetroban----2件: 51, 86 💬
374Oral immunosuppressant----1件: 13 💬
375Oral IR-LD/CD----1件: 6 💬
376Oral iron----2件: 97, 254 💬
377Oral levodopa/carbidopa----1件: 6 💬
378Oral levosimendan1件: Levosimendan1件: Levosimendan 💬 2件: PDE3A,
PDE3B 💬 		10件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
379Oral liposomal iron----1件: 97 💬
380Oral methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
381Oral methylprednisolone 625 MG/24H X3 days1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
382Oral migalastat HCL----1件: 19 💬
383Oral nitric oxide testing----1件: 98 💬
384Oral nutritional supplementation----1件: 2 💬
385Oral OKT3----1件: 97 💬
386Oral PDE5 inhibitors----1件: 86 💬
387Oral pednisolone----1件: 145 💬
388Oral prednisolone----3件: 49, 96, 145 💬
389Oral prednisolone and cyclophosphamide----1件: 222 💬
390Oral prednisolone and SOC----1件: 66 💬
391Oral prednisone 5MG----1件: 49 💬
392Oral probiotic----1件: 291 💬
393Oral reduced L-glutathione----1件: 299 💬
394Oral roflumilast----1件: 299 💬
395Oral SCIO-469 capsule----1件: 46 💬
396Oral sildenafil----1件: 86 💬
397Oral sirolimus----1件: 278 💬
398Oral THC----1件: 13 💬
399Oral treprostinil----2件: 51, 86 💬
400Oral treprostinil (UT-15C) sustained release tablets----1件: 86 💬
401Oral vancomycin----3件: 94, 97, 296 💬
402Oral vancomycin and oral amoxicillin----1件: 94 💬
403Oral viscous budesonide1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
404Oral zamicastat----1件: 86 💬
405Oraplus----1件: 310 💬
406Orbcel-C1件: Allogenic Donor CD362-enriched Human Umbilical Cord-derived Mesenchymal Stem Cells---2件: 94, 95 💬
407ORCA-Q----1件: 13 💬
408Order OF TWO elements OF surgical procedure----1件: 51 💬
409Ordinary meat diet----1件: 97 💬
410ORE1001----1件: 97 💬
411Orelabrutinib1件: Orelabrutinib1件: Orelabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬4件: 13, 49, 61, 63 💬
412Orencia1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬15件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271, 300 💬
413Orencia 125 MG1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
414Orencia 125 MG injektionslösung IM fertigpen1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
415Orencia 125 MG solution FOR injection----1件: 46 💬
416Orencia 125 MG solution FOR injection IN PRE-filled syringe1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬3件: 46, 49, 53 💬
417Orencia 125 MG, solution injectable EN seringue PRéremplie----1件: 46 💬
418Orencia 250 MG polvo para concentrado para SOL. para perfusióN1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
419Orencia 250MG powder FOR concentrate FOR solution FOR infusion1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
420Orencia abatacept1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
421Orencia injektionslösung IN einer fertigspritze1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
422Orencia subcutaneous injection----1件: 46 💬
423Orencia*IV 2FL 250MG+2SIR1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
424Orencia® 125 MG solution FOR injection IN PRE-filled syringe1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 65 💬
425Orfadin1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 3件: Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬2件: 6, 241 💬
426Orfadin oral suspension 4MG/ML1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 3件: Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241 💬
427Orfiril saft----1件: 3 💬
428Originator----2件: 46, 271 💬
429Originator (legacy) drug----4件: 46, 96, 97, 271 💬
430Originator adalimumab1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
431Orilanolimab1件: Orilanolimab1件: Orilanolimab 💬 --1件: 61 💬
432ORIN1001----1件: 85 💬
433Orkambi2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
434Orkambi 100 MG/125 MG FILM-coated tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
435Orkambi 200 MG/125 MG FILM-coated tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
436Orkambi: contains lumacaftor and ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
437ORL-1B----1件: 255 💬
438Orladeyo1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
439ORM-12471 30MG----1件: 51 💬
440ORM-127411件: ORM-12741---1件: 51 💬
441Ormone paratiroideo DA DNA ricombinante----1件: 235 💬
442Orncia----1件: 46 💬
443Ornithine alpha ketoglutarate1件: Ornithine2件: Ornithine ,
Ornithine aspartate 💬 		--1件: 245 💬
444Ornithine transcarbamylase vector1件: Ornithine2件: Ornithine ,
Ornithine aspartate 💬 		--1件: 251 💬
445Orocal----1件: 75 💬
446Oromotor function and nutrition----1件: 113 💬
447ORT247----1件: 2 💬
448Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 MG/0.250 MG----1件: 299 💬
449Ortho-novum 777----1件: 49 💬
450Ortho-novum® 1/35----1件: 46 💬
451Orvepitant1件: Orvepitant1件: Orvepitant 💬 1件: TACR1 💬 3件: Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 85 💬
452Orvepitant maleate1件: Orvepitant1件: Orvepitant 💬 1件: TACR1 💬 3件: Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 85 💬
453ORY2001----1件: 13 💬
454OS440----1件: 13 💬
455OSE-127----2件: 53, 97 💬
456Oseltamivir1件: Oseltamivir2件: Oseltamivir phosphate ,
Oseltamivir 💬 		--2件: 97, 299 💬
457Osilodrostat1件: Osilodrostat2件: Osilodrostat ,
Osilodrostat phosphate 💬 		1件: CYP11B2 💬 2件: Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬1件: 75 💬
458Osilodrostat 10MG1件: Osilodrostat2件: Osilodrostat ,
Osilodrostat phosphate 💬 		1件: CYP11B2 💬 2件: Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬1件: 75 💬
459Osilodrostat 1MG1件: Osilodrostat2件: Osilodrostat ,
Osilodrostat phosphate 💬 		1件: CYP11B2 💬 2件: Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬1件: 75 💬
460Osilodrostat 20MG1件: Osilodrostat2件: Osilodrostat ,
Osilodrostat phosphate 💬 		1件: CYP11B2 💬 2件: Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬1件: 75 💬
461Osilodrostat 5MG1件: Osilodrostat2件: Osilodrostat ,
Osilodrostat phosphate 💬 		1件: CYP11B2 💬 2件: Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬1件: 75 💬
462Osome----1件: 19 💬
463Osrhaat 1 MG/KG IV----1件: 231 💬
464Osrhaat 10 MG/KG IV----1件: 231 💬
465Osrhaat 20 MG/KG IV----1件: 231 💬
466Osrhaat 3 MG/KG IV----1件: 231 💬
467Osrhaat 40 MG/KG IV----1件: 231 💬
468Osrhaat 60 MG/KG IV----1件: 231 💬
469Ossein hydroxyapatite----1件: 75 💬
470Ossido DI azoto----1件: 294 💬
471Ossido nitrico----1件: 86 💬
472Ossitocina----2件: 127, 193 💬
473Ossium VBM-MSC----1件: 96 💬
474OSSM-0011件: Allogenic bone marrow-derived mesenchymal stem cells---1件: 96 💬
475OST-122----1件: 97 💬
476Osteoblast biology study----1件: 238 💬
477Osteomalacia----1件: 238 💬
478Osteopetrosis haploidentical only preparative regimen----5件: 19, 20, 125, 234, 326 💬
479Osteopetrosis only preparative regimen----5件: 19, 20, 125, 234, 326 💬
480Osteopor----1件: 75 💬
481OSU 6162 similar TO (-)-OSU 6162----1件: 6 💬
482OSU6162 similar TO (-)-OSU 6162----2件: 6, 8 💬
483Otelixizumab1件: Otelixizumab1件: Otelixizumab 💬 3件: CD3D,
CD3E,
CD3G 💬 		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 46 💬
484Otezla1件: Apremilast1件: Apremilast 💬 4件: PDE4,
PDE4,
PDE4,
PDE4 💬 		4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬3件: 56, 107, 162 💬
485Otezla - 10 MG + 20 MG + 30 MG compressa rivestita CON film USO orale - blister (PVC/ALU) IN UN astuccio - 4 compresse DA 10 MG + 4 compresse DA 20 MG +19 compresse DA 30 MG1件: Apremilast1件: Apremilast 💬 4件: PDE4,
PDE4,
PDE4,
PDE4 💬 		4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 56, 107 💬
486Other academic sham tutoring----1件: 34 💬
487Other analgesics and antipyretics----1件: 13 💬
488Other antiepileptics----1件: 140 💬
489Other biologic agents----2件: 96, 97 💬
490Other biologic therapies----2件: 96, 97 💬
491Other biological agent----2件: 46, 96 💬
492Other biologics----1件: 46 💬
493Other COX-2 inhibitor----1件: 271 💬
494Other COX-2 inhibitors----1件: 271 💬
495Other crystalloid----1件: 296 💬
496Other disease modifying therapies----1件: 13 💬
497Other disease-modifying therapy----1件: 13 💬
498Other dmards----1件: 46 💬
499Other H1 antagonist----1件: 13 💬
500Other hematological agents----1件: 65 💬
501Other nervous system drugs----2件: 6, 13 💬
502Other NON steroidal ANTI-inflammatory drugs (nsaids) except etodolac----1件: 46 💬
503Other NON-selective nsaids----1件: 271 💬
504Other NON-sponsor pancreatic enzyme replacement therapy----1件: 299 💬
505Other parkinson'S disease treatments----1件: 6 💬
506Other respiratory system products----1件: 299 💬
507Other sources----1件: 228 💬
508Other vasodilator----1件: 51 💬
509Otilimab1件: Otilimab1件: Otilimab 💬 1件: CSF2 💬 16件: Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬1件: 46 💬
510OTL-101----1件: 65 💬
511OTL-1031件: OTL-103---1件: 65 💬
512OTL-103 dispersion FOR infusion1件: OTL-103---1件: 65 💬
513OTL-200----1件: 19 💬
514OTL-200 dispersion FOR infusion----1件: 19 💬
515OTL-200 gene therapy----1件: 19 💬
516OTL-2031件: OTL-203---1件: 19 💬
517Outer membrane vesicles (OMV) from neisseria meningitidis group B strain NZ98/254measured AS amount OF total protein containing THE pora P1.4----1件: 11 💬
518Outpatient rheumatology department----1件: 46 💬
519OV101----2件: 201, 206 💬
520OV101 regimen 1----1件: 201 💬
521OV101 regimen 2----1件: 201 💬
522OVA-treg----1件: 96 💬
523Ovasave----1件: 96 💬
524Ovastat 10001件: Treosulfan1件: Treosulfan 💬 --2件: 13, 65 💬
525Ovastat 1000 MG, powder FOR solution FOR infusion1件: Treosulfan1件: Treosulfan 💬 --1件: 65 💬
526Ovastat 50001件: Treosulfan1件: Treosulfan 💬 --2件: 13, 65 💬
527Ovastat 5000 MG, powder FOR solution FOR infusion1件: Treosulfan1件: Treosulfan 💬 --1件: 65 💬
528Over encapsulated prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
529Over THE counter DHA/EPA dietary supplementation----1件: 301 💬
530OVER-encapsulated 150 MG irbesartan tablets1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
531OVER-encapsulated 75 MG irbesartan tablets1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
532OVER-encapsulated entacapone tablets1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
533OVER-encapsulated irbesartan1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
534OVER-encapsulated irbesartan tablets1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
535OVER-encapsulated modafinil1件: Modafinil1件: Modafinil 💬 --1件: 6 💬
536Overencapsulated azathioprine (imuran) 50 MG tablet1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--1件: 97 💬
537Overencapsulated mesalazine tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
538Overencapsulated prednisolone tablets1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
539Overnight metyrapone test----1件: 193 💬
540Oxabact (TM) - oxalobacter formigenes strain HC11件: Oxabact---1件: 234 💬
541Oxabact - oxalobacter formigenes, strain HC-11件: Oxabact---1件: 234 💬
542Oxabact OC5 - oxalobacter formigenes HC-11件: Oxabact---1件: 234 💬
543Oxabact OC5 - oxalobacter formigenes strain HC-11件: Oxabact---1件: 234 💬
544Oxabact OC5 capsules1件: Oxabact---1件: 234 💬
545Oxabact(TM) - oxalobacter formigenes, strain HC11件: Oxabact---1件: 234 💬
546Oxabact_oxalobacter formigenes strain HC-1----1件: 234 💬
547Oxabact_oxalobacter formigenes, strain HC-1----1件: 234 💬
548Oxabacter formigenes, strain HC1----1件: 234 💬
549Oxacom----1件: 86 💬
550Oxadrop----1件: 96 💬
551Oxalate decarboxylase----1件: 234 💬
552Oxaloacetate1件: Oxaloacetic acid---2件: 6, 11 💬
553Oxaloacetic acid1件: Oxaloacetic acid---1件: 2 💬
554Oxalobacter formigenes1件: Oxabact---1件: 234 💬
555Oxalobacter formigenes, strain HC 11件: Oxabact---1件: 234 💬
556Oxalobacter formigenes, strain HC11件: Oxabact---1件: 234 💬
557Oxalobacterformigenes,strainhc1----1件: 234 💬
558Oxandrolone1件: Oxandrolone1件: Oxandrolone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 211, 285 💬
559Oxanest----1件: 70 💬
560Oxatomide1件: Oxatomide1件: Oxatomide 💬 1件: ALOX5 💬 6件: Arachidonic acid metabolism, Efferocytosis, Fc epsilon RI signaling pathway, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬1件: 113 💬
561OXB-102----1件: 6 💬
562Oxcarbazepine1件: Oxcarbazepine1件: Oxcarbazepine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
563Oxepa----1件: 2 💬
564Oxervate1件: Cenegermin1件: Cenegermin 💬 1件: NGFR 💬 9件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 53 💬
565Oxiconazole1件: Oxiconazole2件: Oxiconazole nitrate ,
Oxiconazole 💬 		--1件: 160 💬
566Oxiklorin----2件: 13, 46 💬
567Oxine1件: Oxyquinoline2件: Oxyquinoline sulfate ,
Oxyquinoline 💬 		--2件: 13, 51 💬
568Oxitriptan1件: Oxitriptan1件: Oxitriptan 💬 --1件: 97 💬
569OXN 10 MG / 5 MG PR----1件: 6 💬
570OXN 10/5 MG PR----1件: 226 💬
571OXN 20 MG / 10 MG PR----1件: 6 💬
572OXN 20/10 MG PR----1件: 226 💬
573OXN 5 MG/2.5 MG PR----1件: 6 💬
574OXN 5/2.5 MG PR----1件: 226 💬
575OXY-001----1件: 46 💬
576Oxybuprocaine1件: Oxybuprocaine2件: Benoxinate hydrochloride ,
Oxybuprocaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
577Oxybutynin and darifenacin1件: Oxybutynin2件: Oxybutynin ,
Oxybutynin chloride 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
578Oxybutynin hydrochloride1件: Oxybutynin2件: Oxybutynin ,
Oxybutynin chloride 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 6, 13 💬
579Oxybutynin, tolterodine, solifenacin1件: Oxybutynin2件: Oxybutynin ,
Oxybutynin chloride 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 53 💬
580Oxycodo----1件: 6 💬
581Oxycodone1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 46, 298 💬
582Oxycodone depot ”sandoz”, depot tablets1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 298 💬
583Oxycodone hydrochloride1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬4件: 6, 70, 226, 298 💬
584Oxycodone naloxone prolonged release tablets1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
585Oxycodone orion1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 70 💬
586Oxycodone/acetaminophen1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 231 💬
587Oxycodone/naloxone prolonged release T2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
588Oxycodone/naloxone prolonged release tablets1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
589Oxycodone/naloxone prolonged release tablets 10 MG /5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
590Oxycodone/naloxone prolonged release tablets 10/5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
591Oxycodone/naloxone prolonged release tablets 20 MG /10 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
592Oxycodone/naloxone prolonged release tablets 20/10 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
593Oxycodone/naloxone prolonged release tablets 5 MG /2.5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
594Oxycodone/naloxone prolonged release tablets 5/2.5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
595Oxycodonhydrochlorid ”lannacher”, depot tablets----1件: 298 💬
596Oxycontin LP 10MG1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
597Oxycontin LP 20MG1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
598Oxycontin LP 5MG1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
599Oxygen1件: Oxygen1件: Oxygen 💬 --13件: 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
600Oxygen - AIR1件: Oxygen1件: Oxygen 💬 --1件: 299 💬
601Oxygen administration1件: Oxygen1件: Oxygen 💬 --1件: 88 💬
602Oxygen flow AT THE optic nerve head measurement1件: Oxygen1件: Oxygen 💬 --1件: 19 💬
603Oxygen GAS FOR inhalation1件: Oxygen1件: Oxygen 💬 --2件: 96, 97 💬
604Oxygen medicinal GAS SOL 100% V/V medicinal GAS, compressed1件: Oxygen1件: Oxygen 💬 --1件: 97 💬
605Oxygen supplementation1件: Oxygen1件: Oxygen 💬 --1件: 86 💬
606Oxygen, liquid1件: Oxygen1件: Oxygen 💬 --2件: 86, 88 💬
607Oxygen, medical GAS1件: Oxygen1件: Oxygen 💬 --1件: 211 💬
608Oxygen-15 water1件: Oxygen1件: Oxygen 💬 --1件: 6 💬
609Oxymatrine1件: Oxymatrine---1件: 37 💬
610Oxynorm----1件: 298 💬
611Oxytocin1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬4件: 127, 168, 193, 226 💬
612Oxytocin (OXT) continuous1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
613Oxytocin 24IU1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 206 💬
614Oxytocin 48IU1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 206 💬
615Oxytocin nasal spray1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬3件: 70, 72, 193 💬
616Oxytocin synthetic1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 6 💬
617Ozanezumab1件: Ozanezumab1件: Ozanezumab 💬 1件: RTN4 💬 1件: Alzheimer disease 💬1件: 2 💬
618Ozanimod1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97 💬
619Ozanimod 0.5 MG1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
620Ozanimod 1 MG1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
621Ozanimod cloridrato1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
622Ozanimod HCI1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
623Ozanimod HCL1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97 💬
624Ozanimod hydrochloride1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97 💬
625Ozanimod oral capsule1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 97 💬
626Ozonated olive OIL----2件: 35, 162 💬
627Ozone1件: Ozone---4件: 49, 51, 70, 226 💬
628Ozone therapy1件: Ozone---1件: 51 💬
629Ozoralizumab1件: Ozoralizumab1件: Ozoralizumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬